210 related articles for article (PubMed ID: 11996812)
21. Low molecular weight heparin-loaded polymeric nanoparticles: formulation, characterization, and release characteristics.
Hoffart V; Ubrich N; Simonin C; Babak V; Vigneron C; Hoffman M; Lecompte T; Maincent P
Drug Dev Ind Pharm; 2002 Oct; 28(9):1091-9. PubMed ID: 12455468
[TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
Woo BH; Jiang G; Jo YW; DeLuca PP
Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769
[TBL] [Abstract][Full Text] [Related]
23. Preparation and characterization of gelatin surface modified PLGA microspheres.
Tsung MJ; Burgess DJ
AAPS PharmSci; 2001; 3(2):E11. PubMed ID: 11741261
[TBL] [Abstract][Full Text] [Related]
24. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres.
Sinha VR; Trehan A
Drug Deliv; 2005; 12(3):133-9. PubMed ID: 16025842
[TBL] [Abstract][Full Text] [Related]
25. Degradation of electrospun PLGA-chitosan/PVA membranes and their cytocompatibility in vitro.
Duan B; Wu L; Li X; Yuan X; Li X; Zhang Y; Yao K
J Biomater Sci Polym Ed; 2007; 18(1):95-115. PubMed ID: 17274454
[TBL] [Abstract][Full Text] [Related]
26. Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs.
Saez A; Guzmán M; Molpeceres J; Aberturas MR
Eur J Pharm Biopharm; 2000 Nov; 50(3):379-87. PubMed ID: 11072195
[TBL] [Abstract][Full Text] [Related]
27. Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration.
Widmer MS; Gupta PK; Lu L; Meszlenyi RK; Evans GR; Brandt K; Savel T; Gurlek A; Patrick CW; Mikos AG
Biomaterials; 1998 Nov; 19(21):1945-55. PubMed ID: 9863528
[TBL] [Abstract][Full Text] [Related]
28. A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery.
Rafiei P; Haddadi A
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109950. PubMed ID: 31499976
[TBL] [Abstract][Full Text] [Related]
29. Influence of PEI as a core modifying agent on PLGA microspheres of PGE₁, a pulmonary selective vasodilator.
Gupta V; Ahsan F
Int J Pharm; 2011 Jul; 413(1-2):51-62. PubMed ID: 21530623
[TBL] [Abstract][Full Text] [Related]
30. Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification.
Lamprecht A; Ubrich N; Hombreiro Pérez M; Lehr C; Hoffman M; Maincent P
Int J Pharm; 1999 Jul; 184(1):97-105. PubMed ID: 10425355
[TBL] [Abstract][Full Text] [Related]
31. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
32. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.
Sánchez A; Villamayor B; Guo Y; McIver J; Alonso MJ
Int J Pharm; 1999 Aug; 185(2):255-66. PubMed ID: 10460920
[TBL] [Abstract][Full Text] [Related]
33. Influence of surface properties at biodegradable microsphere surfaces: effects on plasma protein adsorption and phagocytosis.
Lacasse FX; Filion MC; Phillips NC; Escher E; McMullen JN; Hildgen P
Pharm Res; 1998 Feb; 15(2):312-7. PubMed ID: 9523320
[TBL] [Abstract][Full Text] [Related]
34. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.
Prior S; Gamazo C; Irache JM; Merkle HP; Gander B
Int J Pharm; 2000 Feb; 196(1):115-25. PubMed ID: 10675713
[TBL] [Abstract][Full Text] [Related]
35. Determination of the internal morphology of poly (D,L-lactide) microspheres using stereological methods.
Ehtezazi T; Washington C; Melia CD
J Control Release; 1999 Feb; 57(3):301-14. PubMed ID: 9895417
[TBL] [Abstract][Full Text] [Related]
36. Design of nanosuspensions and freeze-dried PLGA nanoparticles as a novel approach for ophthalmic delivery of pranoprofen.
Abrego G; Alvarado HL; Egea MA; Gonzalez-Mira E; Calpena AC; Garcia ML
J Pharm Sci; 2014 Oct; 103(10):3153-64. PubMed ID: 25091511
[TBL] [Abstract][Full Text] [Related]
37. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
Jiang G; Qiu W; DeLuca PP
Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
[TBL] [Abstract][Full Text] [Related]
38. Protein instability in poly(lactic-co-glycolic acid) microparticles.
van de Weert M; Hennink WE; Jiskoot W
Pharm Res; 2000 Oct; 17(10):1159-67. PubMed ID: 11145219
[TBL] [Abstract][Full Text] [Related]
39. Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages.
Grabowski N; Hillaireau H; Vergnaud J; Tsapis N; Pallardy M; Kerdine-Römer S; Fattal E
Int J Pharm; 2015 Mar; 482(1-2):75-83. PubMed ID: 25448553
[TBL] [Abstract][Full Text] [Related]
40. Critical effect of freezing/freeze-drying on sustained release of FITC-dextran encapsulated within PLGA microspheres.
Kim TH; Park TG
Int J Pharm; 2004 Mar; 271(1-2):207-14. PubMed ID: 15129987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
